Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MEN1 | O00255 | 1/20 | 0.36 |
| ▸ | POLB | P06746 | 1/20 | 0.36 |
| ▸ | MAPT | P10636 | 1/20 | 0.36 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.36 |
| ▸ | TRPV1 | Q8NER1 | 2/20 | 0.34 |
| ▸ | LMNA | P02545 | 1/20 | 0.33 |
| ▸ | CES2 | O00748 | 1/20 | 0.32 |
| ▸ | CES1 | P23141 | 1/20 | 0.32 |
| ▸ | NAAA | Q02083 | 2/20 | 0.32 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.31 |
| ▸ | TP53 | P04637 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL21065793 | 0.83 | CYP1A2 (0.33) | — | |
| SCHEMBL27981153 | 0.75 | NAAA (0.40) | TRPV1CES2CES1NAAA | |
| SCHEMBL27981161 | 0.75 | NAAA (0.40) | TRPV1CES2CES1NAAA | |
| SCHEMBL21065795 | 0.74 | — | — | |
| SCHEMBL21048073 | 0.73 | ALDH1A1 (0.33) | ALDH1A1 | |
| SCHEMBL27942215 | 0.73 | MEN1 (0.35) | MEN1POLBMAPTKMT2ACES2 | |
| SCHEMBL27981431 | 0.73 | MEN1 (0.33) | MEN1POLBMAPTKMT2ANAAA | |
| SCHEMBL23092062 | 0.72 | F10 (0.34) | MEN1POLBKMT2AALDH1A1 | |
| SCHEMBL1142880 | 0.71 | MEN1 (0.33) | MEN1POLBMAPTKMT2ANAAA | |
| SCHEMBL27960412 | 0.70 | MEN1 (0.37) | MEN1POLBMAPTKMT2ALMNA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3494103-B1 | 1-HYDROXYMETHYL-1,2,2,6-TETRAMETHYL-CYCLOHEXANE AND DERIVATIVES THEREOF AND THEIR USE AS AROMA CHEMICALS | BASF SE (DE) | 2021-10-06 | — | — | EP | disclosed |
| US-20190169108-A1 | 1-HYDROXYMETHYL-1,2,2,6-TETRAMETHYL-CYCLOHEXANE AND DERIVATIVES THEREOF AND THEIR USE AS AROMA CHEMICALS | BASF CHEMICALS INDIA PVT. LTD. (IN) | 2019-06-06 | — | — | US | disclosed |
| WO-2018024820-A1 | 1-HYDROXYMETHYL-1,2,2,6-TETRAMETHYL-CYCLOHEXANE AND DERIVATIVES THEREOF AND THEIR USE AS AROMA CHEMICALS | BASF SE (DE) | 2018-02-08 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20190169108-A1 | 1-HYDROXYMETHYL-1,2,2,6-TETRAMETHYL-CYCLOHEXANE AND DERIVATIVES THEREOF AND THEIR USE AS AROMA CHEMICALS | TMT1A, CYP19A1, CYP51A1 | MEN1 718/4885POLB 4250/4885MAPT 1604/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.